Does Rallies show 13F holders for DRIO?

Yes. Rallies tracks hedge fund and 13F ownership data for DRIO, including fund names, share counts, latest tracked quarter, and position changes when available.

Is DRIO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for DRIO. It does not provide personalized investment advice.

DRIO (DarioHealth Corp. Common Stock) Stock Analysis - Hedge Fund Holdings

DarioHealth Corp. Common Stock (DRIO) is a publicly traded Healthcare sector company. As of May 21, 2026, DRIO trades at $8.13 with a market cap of $61.06M and a P/E ratio of 1.46. DRIO moved -2.44% today. Year to date, DRIO is -23.95%; over the trailing twelve months it is -39.39%. Its 52-week range spans $5.94 to $31.00. Analyst consensus is buy with an average price target of $10.50. Rallies surfaces DRIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns DRIO stock?

Hedge funds tracked by Rallies that own DRIO include Renaissance Technologies, Citadel Advisors, and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for DarioHealth Corp. Common Stock.

DRIO Key Metrics

Key financial metrics for DRIO
Metric	Value
Price	$8.13
Market Cap	$61.06M
P/E Ratio	1.46
EPS	$5.46
Dividend Yield	0.00%
52-Week High	$31.00
52-Week Low	$5.94
Volume	0
Avg Volume	0
Revenue (TTM)	$21.19M
Net Income	$-40.74M
Gross Margin	56.55%

Top Hedge Funds Holding DRIO

Renaissance Technologies holds 91.70K shares of DRIO, changed +4.56% as of Dec 31, 2024.
Citadel Advisors holds 71.94K shares of DRIO, changed +8.40% as of Dec 31, 2024.
Two Sigma holds 14.76K shares of DRIO, changed +29.41% as of Dec 31, 2024.

Latest DRIO News

DarioHealth Q1 Revenue Up 24% to $14.8M, EBITDA Loss Narrows — May 13, 2026
DarioHealth Reports 6.7 % Sequential Revenue Growth, Access to 116 Million Covered Lives — May 13, 2026
DarioHealth Study Finds 1,254 Users Achieve Significant Productivity Gains by Week Six — Apr 20, 2026
DarioHealth Appoints 40-Year Executive to Drive Multibillion-Dollar Commercial Partnerships — Apr 13, 2026
DarioHealth Signs 85 Contracts for $12.9M, Eyes $38-42M Break-Even Revenue — Mar 19, 2026

Recent DRIO Insider Trades

Nelson Steven Charles bought 40.00K (~$21.20K) on Aug 27, 2025.
Nelson Steven Charles bought 5.00K (~$4.55K) on Nov 12, 2024.
Nelson Steven Charles bought 5.00K (~$4.02K) on Sep 11, 2024.

DRIO Analyst Consensus

2 analysts cover DRIO: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.50.

Common questions about DRIO

Who owns DRIO stock?: Hedge funds tracked by Rallies that own DRIO include Renaissance Technologies, Citadel Advisors, and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for DarioHealth Corp. Common Stock.
Does Rallies show 13F holders for DRIO?: Yes. Rallies tracks hedge fund and 13F ownership data for DRIO, including fund names, share counts, latest tracked quarter, and position changes when available.
Is DRIO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for DRIO. It does not provide personalized investment advice.